Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials

As the most important viral cause of severe respiratory disease in infants and increasing recognition as important in the elderly and immunocompromised, respiratory syncytial virus (RSV) is responsible for a massive health burden worldwide. Prophylactic antibodies were successfully developed against...

Descripción completa

Detalles Bibliográficos
Autores principales: Broadbent, Lindsay, Groves, Helen, Shields, Michael D, Power, Ultan F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Expert Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474493/
https://www.ncbi.nlm.nih.gov/pubmed/25847510
http://dx.doi.org/10.1111/irv.12313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474493/
https://www.ncbi.nlm.nih.gov/pubmed/25847510
http://dx.doi.org/10.1111/irv.12313

Ejemplares similares